|
Dr. Sherwin has served as chief executive officer and a director of Cell Genesys since March 1990. In March 1994, he was elected chairman of the board. From 1983 to 1990, he held various positions at Genentech, Inc., a biotechnology company, most recently as vice president of clinical research. Prior to 1983, Dr. Sherwin was on the staff of the National Cancer Institute. He currently serves as the chairman of the board of Ceregene, Inc., a subsidiary of Cell Genesys, Inc. He is also a director of Abgenix, Inc., Neurocrine Biosciences, Inc., Rigel Pharmaceuticals, Inc. and privately owned Calyx Therapeutics, Inc. Dr. Sherwin, who also serves as a board member of the Biotechnology Industry Organization, holds a B.A. in biology from Yale University, an M.D. from Harvard Medical School and is board-certified in internal medicine and medical oncology. | 